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In this study, an amphiphilic copolymer folate-succinyl-methionine-chitosan-octyl (FSMCO) was successfully synthesized step by 
step for self-assembling polymeric micelles. The copolymers formed micelle-like nanoparticles by their amphiphilic characteris-
tics and structures were examined by UV-Vis absorption and Fourier transform spectroscopy. The sizes of blank and ICG derivative- 
loaded micelles measured by dynamic light scattering were about 170 and 140 nm, respectively, which were spherical in shape 
with an average zeta potential of 10 mV. Further studies on the stability showed that the micellar solutions maintain their sizes at 
room temperature for 1 month without distinct aggregation or dissociation. ICG derivative was much better photostable after be-
ing entrapped by the new carrier. The prepared FSMCO micelles displayed a good drug loading content (11.7%), entrapment 
efficiency (66.5%) and sustained release rate for the model drug fluorescein. The copolymers demonstrated weeny cytotoxicity 
toward Bel-7402, L02 and A549 cells when incubated for 2 d. Ligands modified micelles endowed preferable cell targeting capa-
bility and beautiful cell inhibition of HCPT-FSMCO on Bel-7402 tumor cells. This kind of polymeric micelles may be a promis-
ing nanovehicle in delivering near-infrared dyes for tumors imaging and chemotherapeutic drugs for cancer therapeutics. 
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For a long time, numerous cytotoxic anticancer drugs dis-
play water-insoluble, poor tumor selectivity, toxic side ef-
fects [1] and the potential of resistance, and so on. The 
above limitations entail an urgent need for developing new 
drug formulation. Increasing interest has being paid to the 
design and development of drug delivery platforms for se-
lective delivery (i.e. targeted delivery) to solid tumors, de-
veloping new non-invasive strategies for the diagnosis and 
treatment of cancer [2]. For instance, nanomicellar systems 
are promising carriers to figure out the above issues, which 
produced significant improvements in tumor accumulation 
of drugs and/or a reduction in systemic toxicity with en-
hanced permeation and retention (EPR) effect [3] and/or 
together with active targeting. Positively charged chitosan is 
an outstanding choice of semi-synthetic natural carrier ma-
terials can be modified to form micelles. Nowadays, folic 
acid (FA) has been proven to mediate favorable transcytosis 
of coupled nanocarriers through folate receptor (FR) [4] 
mediated pathway. The vast expression of FR in many can-
cers makes it a fascinating marker and target molecule for 
cancer diagnosis and therapy [5]. Some drugs conjugated 
with folate and imaging agents have arrived clinical test 
stage [6]. 
Methionine (Met) is sulfur containing essential amino 
acid for normal growth and development in mammals [7]. It 
plays many critical roles in mammalian metabolism such as 
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methylation of DNA, protein synthesis, cell survival, and 
reproduction. Methionine can be transported by LAT1 and 
LAT2 receptors strongly expressed in many malignant cell 
membranes [8]. A characteristic feature had been found that 
many malignant cell lines need a large amount of exoge-
nous methionine named methionine-dependence because of 
the metabolic defect of regenerating methionine, whereas 
non-cancerous cells are generally methionine independent 
[9,10]. Methionine restriction or even methionine-free diets 
was connected to cancer therapy [11]. However, methionine 
in this study was reacted to micelles severed as a targeting 
group. 
With regards to the hydrophobicity of most therapeutic 
drugs and the ligands mentioned previously to enhance anti-
cancer efficacy, we designed a new folate-succinyl-methio-      
nine-chitosan-octyl amphiphilic copolymer for the encapsu-
lation of hydrophobic drugs in this study for the first time, 
in which FA and Met as the bi-model targeting moieties 
emerged an ingenious synergistic effect to amplify tumour 
targeting [12]. This dual receptors targeting would be a 
fresh tactic for delivering drugs effectively and specifically 
than single receptor targeting. Significant advances have 
been made in synthetic methodology, such that prepared the 
kind of micelles with highly controlled size, shape, surface 
charge and physicochemical characteristics, with FA and 
Met further decorated in their surface in order to improve 
biocompatibility and achieve active targeting. Fluorochromes, 
fluorescein and ICG derivative, were successfully encapsu-
lated by FSMCO micelles. Identification, in vitro release 
and in vitro cytotoxicity of the polymeric micelles were also 
studied in detail. These results suggest that this novel 
FSMCO copolymer based on the polysaccharide is likely to 
be a promising nanocarrier for in vivo tumor imaging and 
anticancer drug delivery. 
1  Materials and methods 
1.1  Materials 
Chitosan, with deacetylation degrees of 91% and average 
molecular weight (MW) of 100 kD was purchased from 
Aoxing Biotechnology Co. Ltd. (Zhejiang, China). Folic 
acid (FA, folate, MW 441), 1-ethyl-3-(dimethylaminopropyl) 
carbodiimide hydrochloride (EDC·HCl), N,N′-dicyclohex-      
ylcarbodiimide (DCC), N-hydroxysuccinimide (NHS) and 
methyl thiazolyl tetrazolium (MTT) were all purchased 
from Sigma-Aldrich (St. Louis, USA). Indocyanine Green 
(ICG) derivative (MW 689) was prepared by our research 
group. L-Methionine, hydroxycamptothecine (HCPT) and 
fluorescein were purchased from Aladdin reagent (Shanghai, 
China). RPMI 1640 medium, trypsin, penicillin, calf serum, 
streptomycin and ethylenediaminetetraacetic acid (EDTA) 
were all purchased from Invitrogen-Life Technologies (Carls-
bad, CA, USA). Many other reagents used in this study were 
all commercially obtained from Shanghai Chemical Reagent 
Company (Shanghai, China) with analytical reagent grade. 
Human hepatoma cell lines (Bel-7402), human lung car-
cinoma cell lines (A549) and immortal hepatic cell lines 
(L02) were all purchased from American Type Culture Col-
lection (ATCC, Manassas, VA, USA). 
1.2  Synthesis of folate and methionine co-modified 
chitosan micelles 
(i) Preparation of N′-methionine-chitosan-N-octyl (MCO).  
In brief, 0.51 g octyl aldehyde was dropwise added to 0.5 g 
chitosan dissolved in 40 mL 1% acetic acid, followed by 
constant stirring for 4 h at room temperature. Then, the re-
sultant solution pH was adjusted to 4.5. After that, 1.6 mL 
NaBH4 solution (10 mg/mL) was rather slowly added drop 
by drop and followed by continuous stirring for 12 h. After 
conjugating octyl to the reactive amino groups of the chi-
tosan, the product solution (chitosan-octyl, CO) was filtered 
and neutralized with gradual addition of 5% (w/v) NaOH 
solution, then purified by dialyzing against distilled water 
(molecular weight cut off (MWCO) 10 kD). 
Then, diluted methionine was slowly dropwise added to 
the mixed solution (acidified to pH 5.0) of chitosan-octyl and 
excess EDC/NHS (molar ratio of Met:EDC:NHS=1:5:1), 
constant stirring for 8 h at room temperature to completely 
react to the remainder amino groups of chitosan. Still, a dial-
ysis was done to purify the reaction product (Met-chitosan- 
octyl, MCO). 
(ii) Synthesis of succinic anhydride modified MCO 
(SMCO).  In order to obtain negatively charged nanoparti-
cles, succinic anhydride dissolved in acetone (3 g/17 mL) 
was reacted with MCO (2 g) for 36 h. After that, the nano-
particles were washed several times with deionized water 
(DI water). 
(iii) Preparation of folate-SMCO (FSMCO) micelles.  - 
COOH group of FA (25 mg) dissolved in anhydrous dime-
thyl sulfoxide (DMSO, 2.5 mL) was activated for 4 h in the 
presence of DCC and NHS (molar ratio of FA:DCC:NHS= 
1:1.2:2) [13], followed by centrifuging and filtering to re-
move the side product dicyclohexylurea (DCU) precipitate, 
then continuous stirring in the dark for 12 h at room tem-
perature to crosslink FA-NHS to a balanced amount of 
amino groups of SMCO, dialyzed, frozen and lyophilized. 
1.3  Characterization of FSMCO micelles 
To identify FSMCO, UV-Vis absorption spectra were used 
to analyze the synthesized products using UV-Vis spectro-
photometer (JH 754PC, China). Successful preparations of 
FSMCO micelles were also confirmed by Fourier transform 
infrared (FTIR) spectra (Nicolet ECO 2000, USA). 
1.4  Preparation of model drug-loaded FSMCO micelles 
To figure out the maximal drug loading content, the optimum 
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weight ratios (Model drugs: FSMCO=2:1, 1:1, 1:2, 1:4, 
1:5, 1:6) were investigated firstly. Model drugs with dif-
ferent hydrophobicities, fluorescein and ICG derivative, 
were dissolved in DMSO and dropwise added to FSMCO 
solution respectively with magnetic stirring at room tem-
perature. Then, the resultant mixture was dialysed in dialy-
sis tube (MWCO 10 kD) against DI water for 2 d, followed 
by centrifuging at 5000 r/min for 10 min to remove unload-
ed model drugs, the resultant supernatant was lyophilized 
and dissolved in dimethyl formamide (DMF), the absorb-
ance of the resultant solutions at the absorption peaks of the 
two model drugs were analyzed, respectively. 
The drug encapsulation efficiency and drug loading con-
tent were measured based on the following equations [14]: 
encapsulation efficiency (EE)=(mass of drug encapsulated 
in micelles/mass of drug in feed)×100%; drug loading con-
tent=(mass of drug encapsulated in micelles/mass of drug 
encapsulated micelles)×100%. 
1.5  Particle size and zeta potential measurement 
Particle size is increasingly recognized as an important pa-
rameter in the effective delivery of therapeutic agents by 
particulate vehicles, as well as size distribution can have a 
profound effect on the drug release profile, organ targeting 
and the efficiency in penetrating tissues and cells [15]. In 
this study, the average sizes and polydispersity of blank and 
ICG derivative-loaded FSMCO micelles were characterized 
by Particle Size Analyzers (Brookhaven Instruments Cor-
poration, Austin, Texas, USA) in phosphate-buffered saline 
(PBS, pH 7.4). Meanwhile, the zeta potential, a measure of 
the surface charge on the micelles, was determined by Zeta 
Potential Analyzers (Brookhaven Instruments Corporation, 
Austin, Texas, USA) in PBS (pH 7.4) solution. 
1.6  Micelle stability 
To study the storage stability, blank micelles and ICG de-
rivative-loaded FSMCO micelles were suspended in PBS 
(1.0 mg/mL) and stored in dark place at room temperature 
for a month. Time-dependent change in micellar size was 
monitored by Particle Size Analyzers to evaluate the stabil-
ity of the micelles. 
1.7  Transmission electron microscopy (TEM) of micelles 
The morphological evaluation of diluted blank FSMCO 
micelles and ICG derivative-loaded FSMCO micelles were 
performed using transmission electron microscope (TEM, 
Philips FEI Tecnai G2 20s-TWIN, the Netherlands) with 
accelerated voltage of 200 kV. Samples were prepared by 
dropping diluted micelles solutions on carbon-coated cop-
per grids and allowed them to dry at room temperature. 
The specimens on the copper grids were avoided to be 
stained. 
1.8  Status study of model drug in micelles 
Fluorescein and ICG derivative were selected with the ex-
citation and emission wavelengths 488/525 nm and 765/808 
nm, respectively. The former is suitable for in vitro cellular 
study under confocal microscopy and the latter is available 
in vivo targeting evaluation under near infrared imaging 
system. 
Optical properties about absorption and fluorescence of 
free and incorporated ICG derivative were measured by 
UV-Vis spectrophotometer and S2000 spectrometer (Ocean 
Optics, USA), respectively. In addition, relative fluores-
cence intensity was measured under successive exposure to 
the laser (765 nm) for 1 h to evaluate the photostability of 
free and incorporated ICG derivative, and data was gathered 
every 5 min. 
1.9  In vitro drug release study 
Fluorescein-loaded micelles and ICG derivative-loaded mi-
celles were prepared to investigate the release profiles. In 
vitro drug release studies were carried out by a dialysis 
(MWCO 10 kD) using PBS (pH 7.4). Fluorescein and ICG 
derivative-loaded FSMCO solution was transferred into 
dialysis bags and dialyzed against 30.0 mL PBS in dark 
environment with constant agitation at 95±5 r/min and 37°C, 
respectively. At selected time intervals, 3 mL dialysate was 
withdrawn and replaced with 3 mL fresh PBS to make the 
volume fixed at every time point during the assay. The con-
centration of the released model drugs was determined by 
UV-Vis spectrophotometer and calculated according to a 
previously obtained calibration curve. The release experi-
ments were conducted in triplicate. 
1.10  In vitro cell viability studies 
The cytotoxicity of FSMCO was determined by employing 
MTT assay [16] against A549, L02 and MCF-7 cells. Cells 
were seeded into 96-well plate and cultivated at 37°C for  
24 h. After that, cells were exposed to 200 L a series of 
concentrations of FSMCO solutions (0.0625, 0.125, 0.25, 
0.5, 1, 2 mg/mL) for another 48 h. After incubation, FSMCO 
solutions were replaced with 180 µL fresh RPMI 1640 me-
dium and 20 µL MTT solutions (5 mg/mL). Culture medium 
was removed after 4 h, and 200 L DMSO was added into 
each well with continuously shake for 10 min to dissolve the 
formazan crystals. The absorbance at 490 nm was measured 
using a Microplate Reader (Model 500; BIORAD, USA). 
Thus the metabolic activities of the cells were defined [17] 
by the following equation: 
  a bCell viability % OD OD 100%,   
where ODa was the optical density of the cells incubated 
with FSMCO micelles, and ODb was the optical density of 
the cells treated in the absence of FSMCO micelles only 
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with RPMI 1640 medium. 
1.11  Targeting ability investigation of FSMCO at  
cellular level 
In order to find out the target properties of the micelles at 
cellular level, Bel-7402 and A549 cells with a density of 5× 
105 cells/well in confocal laser scanning microscopy (CLSM) 
culture dishes were incubated with fluorescein loaded na-
noparticles. 2 mL culture medium containing 0.1 mg fluo-
rescein loaded succinyl-octyl-chitosan micelles [13] (SOC, 
pre-synthesized by our laboratory) or FSMCO was added to 
each well, medium was detached after 6 h incubation time 
and the cells were washed thrice with PBS. The fluores-
cence of the cells was obtained using CLSM (BX60, Olym-
pus, Japan) under 488 nm excitation. Additionally, Bel-7402 
cells were exposed to 2 mL culture medium containing free 
FA or Met or both as well as fluorescein-loaded nanoparti-
cles for competition assay. Subsequent procedure was acted 
as the method described above. 
1.12  Inhibition effect of drug-loaded FSMCO micelles 
on Bel-7402 cells 
HCPT was encapsulated into FSMCO micelles to evaluate 
the suppression on Bel-7402 cells, cells were seeded in 96- 
well culture dishes and cultured for 24 h. HCPT, HCPT- 
SOC, HCPT-FSMCO at various concentrations (from 3.125 
to 100 g/mL) suspended in PBS were added to cell culture 
dishes and incubated for 24 h. MTT assay was also carried 
out to detect the livability of Bel-7402 cells. 
2  Results and discussion 
2.1  Synthesis and characterization of FSMCO 
FA, Met, CO, MCO and FSMCO were studied by UV-Vis 
detection, and the results (Figure 1) showed that FSMCO had 
all three maximum absorption of Met (210 nm), CO (228 nm) 
and characteristic absorption peaks of FA (280 and 362 nm), 
which confirmed the successful acquisition of FSMCO. 
Compared to chitosan, 1555 cm1 appeared in the FTIR 
spectrum of MCO and FSMCO, which usually caused by 
secondary amines, illustrating part of amino groups of chi-
tosan were substituted by Met and/or octyl (Figure 2). The 
new peaks at 2925 and 2855 cm1 were attributed to ali-
phatic C-H stretching band of methyl groups of the alkyl 
chain (–(CH2)7–CH3) [18], implied that octaldehyde was 
reacted to chitosan. The peak at 1645 cm1 was C=O stretch-
ing band of acetyl group [19], confirmed that Met was linked 
to chitosan. Furthermore, the peak presented at 1700 cm1 
was the C=O stretching vibration of carboxyl group, de-
clared that succinic anhydride was reacted to part of the 
amino groups of MCO. The appearance of the peak at  
1600 cm1 in the FTIR spectrum of FSMCO was related to  
 
Figure 1  Identification of FSMCO with UV-Vis: absorbance of Met, FA, 
CO, MCO, and FSMCO.  
 
Figure 2  Identification of FSMCO with FTIR: the FTIR spectra of chi-
tosan (a), MCO (b) and FSMCO (c). 
benzene ring of the folic acid. Both the above characteriza-
tions showed that the desired copolymers were synthesized 
successfully. 
2.2  Size and morphology of micelles 
Studies have shown that the perfect particle size for cancer 
treatment in the range of 70 to 200 nm, resulting in efficient 
accumulation in solid tumor tissues [20,21]. The hydrody-
namic diameters of blank micelles and ICG derivative- 
loaded FSMCO micelles in PBS determined by dynamic 
light scattering (DLS) were shown in Figure 3. Protonation 
was avoided in PBS with pH 7.4 [22], and the size of the 
blank micelles was about 170 nm, and the size of the ICG 
derivative-loaded micelles was about 140 nm, which sug-
gested that the micelle nanoparticles had satisfactory di-
mensions. 
The TEM micrograph (Figure 4) clearly revealed that the 
blank micelles and ICG derivative-loaded micelles were 
spherical in shape, which had a homogeneous size distribu-
tion (Polydispersity <0.2) with an average size of 140 and 
110 nm, respectively. When encapsulate with hydrophobic  
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Figure 3  Size distributions of blank FSMCO micelles (a), and ICG derivative-loaded FSMCO micelles (b) at 25°C in PBS (pH 7.4).  
 
Figure 4  Transmission electron microscope (TEM) pictures of blank FSMCO (a), and ICG derivative-loaded FSMCO micelles (b).  
dye ICG derivative, the hydrophobic interaction between 
ICG derivative and octyl would bring about the hydropho-
bic core much more intense, representing the decreased size 
compared to blank micelles; one ICG derivative molecule 
possesses two “–COO–”, repulsive force increased among 
micelles because of the negative charge of the entirety in-
creased after encapsulating with ICG derivative, thus ac-
quired better dispersibility tested by Particle Size Analyzers. 
The smaller sizes were observed by TEM as compared to 
that determined by DLS is most likely due to the evapora-
tion of water around the micelles during the sample prepa-
ration of TEM, which caused the shrinkage of the hydro-
philic shell [23]. 
The zeta potential gives an indication in the physical sta-
bility of the colloidal system in vitro and in vivo, and affects 
its interaction with proteins and cell membranes in blood 
vessels [24]. MCO was positively charged, and blank mi-
celles and ICG derivative-loaded micelles were both nega-
tively charged about 10 mV. It was proved that succinic 
anhydride was successfully reacted to MCO. Thereby, neg-
atively charged colloidal system would barely adhere to 
cells in vessels when intravenous injection. 
2.3  Stability of micelles 
Diluted blank micelles solution and ICG derivative-loaded 
micelles solution were used in the stability study. The re-
sults (Figure 5) indicated that the micelles were almost  
 
Figure 5  Particle size of blank FSMCO micelles, and ICG derivative- 
loaded FSMCO micelles at 25°C in PBS (pH 7.4) as a function of time. 
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steady during storage at room temperature (25°C) for a 
month. No change in the micelle size and size distribution 
in the first 10 d and no precipitation of ICG derivative were 
found during the month, moreover, ICG derivative-loaded 
micelles were more stable than blank micelles because of 
the similar polarity between octyl and ICG derivative which 
enhanced the hydrophobic association action.  
2.4  Drug loading and in vitro drug release  
We concluded the maximum drug loading content with the 
feed ratio 1:5. The optimal drug loading content was 11.74% 
for fluorescein (EE=66.52%), while the drug loading con-
tent was just 37.46% for ICG derivative (EE=6.97%). The 
drug loading content and EE for fluorescein were more than 
that of the more hydrophobic ICG derivative which may be 
due to the rapid precipitate of the intense hydrophobicity 
when at the dynamic drug loading process in aqueous solu-
tion. Consequently, precipitation resulted in lower entrap-
ment into the inner hydrophobic core. 
Figure 6 shows in vitro release profile of model drugs 
from FSMCO micelles at 37°C in PBS solution (pH 7.4). 
Obvious burst release was observed in the release profile of 
fluorescein and the cumulative percentage release reached 
about 70% during the initial 40 h. More than 90% of the 
loaded fluorescein was released in the following slow re-
lease stage for up to 96 h. In contrast to fluorescein, the ICG 
derivative cumulative percentage release by 240 h reached 
only 59% with a continuous slow-release started from about 
the 5th hour. The results were manifest and indicated that 
the release rate of model drug was closely related to the 
hydrophobicity, the hydrophobic binding force of fluores-
cein to the inner octyl of micelles was much weaker than 
that of ICG derivative because of its inferior hydrophobicity, 
which induced a fairly fast release rate for fluorescein from  
 
Figure 6  Release kinetics of fluorescein-loaded FSMCO micelles and 
ICG derivative-loaded FSMCO micelles in PBS (pH 7.4, 37°C). Inset: The 
release kinetics of the initial 72 h. Data were given as mean ± SD (n=3). 
FSMCO carrier. 
2.5  Optical characterization of entrapped ICG derivative 
ICG derivative was easily packaged into FSMCO by hy-
drophobic association effect. The excitation and emission 
spectra for ICG derivative and ICG derivative-loaded FSMCO 
are shown in Figure 7(a) and (b). No change was observed  
 
Figure 7  Optical characterization of free ICG derivative and ICG derivative- 
loaded FSMCO. (a) Absorbance spectra; (b) fluorescence spectra; (c) light 
stability. 
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in optical properties of ICG derivative-loaded micelles com-
pared to free ICG derivative, including maximum absorp-
tion peak, excitation wavelength and emission wavelength. 
Furthermore, better resistance to fluorescent bleaching was 
found after ICG derivative being encapsulated into FSMCO 
micelles (Figure 7(c)), the relative intensity of fluorescent 
emitted from ICG derivative encapsulated by FSMCO was 
strengthened from 1000 to nearly 2200 in the beginning 20 
min, slow decrease was found in the following time, but still 
much higher than the relative intensity of fluorescent emit-
ted from free ICG derivative. It was suggested that ICG 
derivative together with FSMCO micelles can be used to 
trace the dynamic process of FSMCO in the mouse model 
evaluated by near-infrared imaging system [25].  
2.6  Cytotoxicity assay of FSMCO micelles 
The in vitro cytotoxicities of prepared FSMCO against Bel- 
7402, L02 and A549 cells are shown in Figure 8. The com-
posite was proved to be weeny cytotoxicity even in 2 mg/mL 
by MTT assay. After the 48 h incubation, cell viabilities in 
the presence of micelles at different concentrations from 
0.0625 to 2 mg/mL were more than 93%, even at high con-    
 
Figure 8  Cytotoxicity study of FSMCO micelles against A549 cells, 
Bel-7402 cells, and L02 cells. Data represent mean ± SD (n=5).  
centration. It was therefore presupposed that the micelles 
exhibited reasonable biocompatibility. The confirmation of 
little or nontoxicity of chitosan-based micelles was also 
reported in other places [26,27]. 
2.7  Cellular uptake of nanoparticals 
The exceeded expression of LAT1, LAT2 and FA receptors 
of Bel-7402 cells was previously reported, while the ex-
pression levels of both receptors on A549 cells (used as 
control) were low [13,28]. In order to prove the increased 
uptake in tumor cells, results (Figure 9) were observed by 
fluorescence microscope. Fluorescence intensity of fluores-
cein in cells was decreased as the following order: FSMCO- 
fluorescein>FSMCO-fluorescein together with Met>FSMCO- 
fluorescein together with FA>FSMCO-fluorescein together 
with FA and Met>SOC-fluorescein. Extra added free FA 
and Met in medium reduced the endocytosis because of the 
competitive inhibition. By contrast, low fluorescence inten-
sity can be seen in A549 cells visibly. These results indicated 
that both the presence of FA and Met modified on micelles 
can promote cellular uptake effectively by Bel-7402 cells. 
2.8  Inhibition effect of HCPT loaded FSMCO micelles 
on celluar level 
The results (Figure 10) of MTT assay confirmed that the anti- 
tumor efficacy was advanced as the concentration of drug 
increased. After 24 h incubation, therapeutic effects were 
shown to varying degrees: HCPT-FSMCO>HCPT>HCPT- 
SOC. HCPT-FSMCO put up greatest cell inhibition. Cell 
viability was down to 46% at the maximum concentration 
of HCPT-FSMCO due to the receptors-mediated endocyto-
sis. Results here demonstrated that folic acid and methio-
nine played indispensable roles in increasing the cytotoxic 
effect of HCPT.  
3  Conclusions 
The newly developed folate-succinyl-methionine-chitosan- 
octyl amphiphilic copolymer in this paper could self-assemble  
 
Figure 9  The fluorescence microscopy images of Bel-7402 cells (a) and A549 (b) tumor cells after incubated with fluorescein loaded micelles (scales in 
images were 20 m).
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Figure 10  Anti-tumor capacity assessment of HCPT-FSMCO, HCPT- 
SOC, HCPT in Bel-7402 tumor cells. Cell viability (%) at 24 h. 
into core-shell micelles in aqueous medium by hydrophobic 
interactions, which proved to be an excellent water-insoluble 
drug reservoir due to the octyl as the hydrophobic core. 
FSMCO micelles may be used for drug delivery of hydro-
phobic anti-cancer drugs without any influence to drugs, 
which showed enhanced stability indeed. The obtained na-
nomicelles had spherical shape with uniform negatively 
charged particle size, more cyto-compatible with cancer 
cells or normal cells. Fluorescein encapsulation efficiency 
as high as 66.5% was achieved and drug loading reached to 
11.7%. Dual-receptor meditated selective Bel-7402 cells 
targeting capability and preferable cell inhibition efficacy 
were verified. These particular properties of FSMCO con-
jugates demonstrated that it is a promising injectable nanosys-
tem for drug delivery and imaging in cancer research. 
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